<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HCFB79B8702D342E4BB5C604694A3EA12" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 449 IH: Synthetic Drug Awareness Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-01-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 449</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170111">January 11, 2017</action-date><action-desc><sponsor name-id="J000294">Mr. Jeffries</sponsor> (for himself, <cosponsor name-id="M001181">Mr. Meehan</cosponsor>, <cosponsor name-id="G000566">Mr. Gowdy</cosponsor>, <cosponsor name-id="C001092">Mr. Collins of New York</cosponsor>, and <cosponsor name-id="B001251">Mr. Butterfield</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require the Surgeon General of the Public Health Service to submit to Congress a report on the
			 effects on public health of the increased rate of use of synthetic drugs.</official-title></form>
	<legis-body id="HCA3DD6B9904649E29C3463CCA79F64E4" style="OLC">
 <section id="HBC52730869CB48E884D393D265A77B6B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Synthetic Drug Awareness Act of 2017</short-title></quote>.</text> </section><section id="H8AD13553359244B99C4162AAB7908870"><enum>2.</enum><header>Report on effects on public health of synthetic drug use</header> <subsection id="H2A1E0660FDEC411D96F15BF3E0971BE6"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than three years after the date of the enactment of this Act, the Surgeon General of the Public Health Service shall submit to Congress a report on the effects on public health of the increase since January 2010 in the rate of use of synthetic drugs in the United States by individuals who are at least 12 years of age but not more than 18 years of age.</text>
 </subsection><subsection id="H31F04BC3A8EA4831871E974DF0E8D897"><enum>(b)</enum><header>Synthetic drug defined</header><text>For purposes of subsection (a), the term <term>synthetic drug</term> means a drug which is developed and manufactured to avoid control under the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/801">21 U.S.C. 801</external-xref> et seq.).</text>
			</subsection></section></legis-body></bill>


